article thumbnail

Keep Your 2021 Sales Pipeline Full Using the Selling Lessons of 2020

Integrity Solutions

Now that 2020 is in the rear view mirror, most of us are ready to bid good riddance to an incredibly tumultuous year and do our best to forget it. But before you barrel ahead into 2021 and look for signs of returning to the “good old days,” sales leaders and their teams have a lot to learn from 2020.

article thumbnail

FibroGen CEO Conterno, who scrapped post-Lilly plans over roxadustat hype, resigns after launch setbacks

Fierce Pharma

Hopes around FibroGen’s anemia drug roxadustat were high in early 2020 when Enrique Conterno arrived as the company’s new CEO. To support Wettig, Conterno plans to stick around as a special advisor to the CEO during a transition period.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

An Interview with Dr. Sandra Horning, 2020-21 HBA Woman of the Year

Pharma Marketing Network

Tune into an exclusive Pharma Marketing Network (PMN) interview with Amy Turnquist, a member of the PMN Editorial Advisory Board and Dr. Sandra Horning, the Healthcare Businesswomen’s Association Woman of the Year (WOTY) 2020-21. Dr. Horning holds a very special place in HBA history as the only woman to hold the WOTY title for two years.

article thumbnail

Fewer Prescribers Are Driving NBRx Than You Think—Here’s Why

PM360

By 2020, that percentage plummeted to just 8%. While it’s unsurprising that patients flock to these cheaper alternatives to treat common conditions, generic medications aren’t as accessible for specialized conditions, which gives pharma marketers an opportunity to drive scripts where the market is less crowded. References: 1.

article thumbnail

Avadel Pharmaceuticals launches excessive daytime sleepiness therapy in US

Pharmaceutical Technology

The regulatory approval was based on the findings from the pivotal Phase III REST-ON clinical trial completed in March 2020. The US Food and Drug Administration (FDA) granted final approval to the therapy in May 2023.

article thumbnail

Alzheimer’s disease not forgotten as FDA oversees record number of designations awarded

Pharmaceutical Technology

The FDA has seen a record surge in review designations being awarded over the last two years for Alzheimer’s indications, with 12 review designations being awarded to drugs between 2020 and 2022. The development of novel and effective drugs is of special importance. ©GlobalData.

FDA 98
article thumbnail

10 Factors to Consider When Choosing the Right Programmatic Analytics Platform

Healthcare Success

more on programmatic display ads than in 2020 —and it’s easy to understand why. . Specializes in real-time programmatic marketing automation technologies, products, and services, designed to personalize digital content delivery to users. Specializes in distributing and promoting content using real-time, data-driven audience targeting.